Calculation of drug dosage and body surface area of children

J A Lack1, M E Stuart-Taylor

  • 1Anaesthetic Department, Salisbury Hospital.

Insights

A new drug dosage calculation method for children, based on weight, is proposed. This method is simpler and more accurate than existing body surface area (BSA) calculations, potentially reducing prescription errors.

Area of Science:

  • Pediatric Pharmacology
  • Drug Dosage Calculation
  • Clinical Pharmacy

Background:

  • Current drug dosage recommendations for children often rely on body surface area (BSA).
  • Existing pediatric drug dosing guidelines, based on age, weight, or BSA, lack both accuracy and simplicity for routine clinical application.
  • The British National Formulary and other key textbooks advocate for BSA-based dosing in pediatric populations.

Purpose of the Study:

  • To introduce and evaluate a novel, simplified drug dosage calculation method for pediatric patients.
  • To compare the proposed method's accuracy and practicality against conventional weight-based (mg kg-1) and BSA-based regimens.
  • To reduce the incidence of major prescription errors in pediatric drug administration.

Main Methods:

  • The study describes various established pediatric drug dosing rules.
  • A new clinical dosing rule is proposed: for children weighing up to 30 kg, the dose is (weight x 2)% of the adult dose; for those over 30 kg, it is (weight + 30)% of the adult dose.
  • The proposed percentage-based method is compared to traditional mg kg-1 dosing and BSA calculations.

Main Results:

  • The proposed weight-based percentage method more closely follows the body surface area (BSA) curve compared to the standard mg kg-1 regimen.
  • Implementation of this simplified dosing approach is anticipated to decrease the frequency of significant prescription errors.
  • The new method offers a more accurate and straightforward alternative for routine pediatric drug dosing.

Conclusions:

  • The novel weight-based percentage method provides a more accurate and simpler approach to pediatric drug dosing than conventional regimens.
  • This simplified calculation method aligns better with body surface area (BSA) estimations.
  • The proposed method has the potential to enhance medication safety in children by minimizing dosing errors.

Related Concept Videos

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...